Alcon
Alcon manufactures intraocular lenses, which replace the natural lens removed during cataract surgery. It is the second largest division of Swiss group Novartis.
Alcon operates in more than 75 countries, serving 180 markets and employing more than 24,000 people. The Cork centre manufactures AcrySof® intraocular lenses, the most frequently implanted lenses worldwide.
Technologies and processes featured at the Cork site include mould-tool manufacturing, monomer formulation, casting, curing/polymerization, high precision optical measurement and packaging. Approximately 400 employees work at the site.
Financial Data
-
31st Dec 18 Source: CRO
- €58.7 million turnover
-
€2.3 million
profit - 413 employees
-
31st Dec 17 Source: CRO
- €46.4 million turnover
-
€1.5 million
profit - 404 employees
- 5 more years available »
Ranking
By Turnover
(€58.7 million)- 659th in Top Companies
- 63rd in Pharma
By Employees
(413)- 417th in Top Companies
- 37th in Pharma
- 413
- €58.7 million
Employees
- Jackie Murphy Country Manager
Latest News
- 12:11pm LSE to abandon lossmaking derivatives exchange
- 11:44am Aer Lingus reiterates need for change after ground crew rejects proposals
- 11:03am Google to buy Manhattan office building for $2.1bn
- 10:14am Britain refers record label dominance to competition authority
- 9:54am European shares rise on Evergrande relief, gains in travel and leisure